Viking Global Opportunities Illiquid Investments Sub-Master LP
SEC CIK 1629482 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BBIO | BridgeBio Pharma, Inc. | 10% | 22.06M | — | $106.99M | 1 | 2025-01-31 | 2025-01-31 |
| APG | APi Group Corp | 10% | 1.91M | — | $104.07M | 1 | 2024-03-05 | 2024-03-05 |
| FDMT | 4D Molecular Therapeutics, Inc. | 10% | 4.25M | — | $10.55M | 1 | 2024-01-04 | 2024-01-04 |
| AMLX | Amylyx Pharmaceuticals, Inc. | 10% | 4.68M | $43.70M | $41.72M | 3 | 2022-01-11 | 2022-09-08 |
| RLYB | Rallybio Corp | 10% | 3.39M | $10.48M | — | 2 | 2021-07-29 | 2021-07-29 |
Most active insiders at BBIO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Kumar Neil | CEO, Dir | — | $61.54M |
| 2 | Cook Jennifer E. | Dir | — | $21.92M |
| 3 | MCCORMICK FRANK | Dir | — | $13.31M |
| 4 | Lo Andrew | Dir | — | $6.32M |
| 5 | Ellis Andrea | Dir | — | $5.65M |
| 6 | Valantine Hannah | Dir | — | $4.37M |
| 7 | DANIELS RONALD J | Dir | — | $3.89M |
| 8 | Trimarchi Thomas | Pres, CFO | — | $3.03M |
| 9 | Scott Randal W. | Dir | — | $2.09M |
| 10 | Apuli Maricel | CAO | — | $621.7K |
Viking Global Opportunities Illiquid Investments Sub-Master LP made no open-market trades at BBIO in the last 12 months.
Transactions 8
Purchase Sale Sale after option exercise All abbreviations